Firm
In the second of a two-part article, Gabrielle Faure-André and Stéphanie Garçon at Santarelli unpick EPO, UPC and French case law to assess the importance of clinical development timelines in inventive step analyses
Public figures are turning to trademark protection to combat the threat of AI deepfakes and are monetising their brand through licensing deals, a trend that law firms are keen to capitalise on
Tom Melsheimer, part of a nine-partner team to join King & Spalding from Winston & Strawn, says the move reflects Texas’s appeal as a venue for high-stakes patent litigation
AI patents and dairy trademarks are at the centre of two judgments to be handed down next week
Sponsored
Sponsored
-
Sponsored by LexOrbisManisha Singh and Simran Bhullar of LexOrbis take a look at the surprising court record of a persistent offender deceptively targeting Indian health and beauty brands -
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law summarises the eligible drugs, the re-examination period and strategies available for companies
-
Sponsored by ABE & PartnersTakanori Abe of Abe & Partners previews potential suggested changes to Japan’s patent world
-
Sponsored by MaiwaldEva Ehlich, Angela Zumstein and James Neuhaus of Maiwald note their observations on oral proceedings before the Enlarged Board of Appeal
-
Sponsored by Gün and PartnersBarış Kalaycı and Direnç Bada of Gün and Partners assess the benefits of filing a criminal case based on trademark infringement for counterfeit products subject to the crime of smuggling
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula of RNA, Technology and IP Attorneys takes a look at the new due diligence mechanism and considers why this has caused a backlash
